Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could an abdominal belt ease back pain for dialysis patients?

NCT ID NCT07679425

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study investigates whether a pneumatic compression device worn around the upper abdomen can improve diaphragm movement and reduce pain in people on hemodialysis who have chronic low back pain. Fifty participants will use the device during breathing exercises for 12 weeks. Researchers will measure changes in diaphragm function, pain intensity, and walking ability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pneumatic compression device
What this could lead to
If effective, this device could offer a drug-free way to ease back pain and improve breathing function in people on dialysis.
What could go wrong
This is a small, early-stage study with only 50 participants, so results may not apply to everyone. The device may not provide lasting relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients have been on regular hemodialysis (three sessions a week) at least 6 months before the start of the study * Patients 'Age between 40 and 60 years old * Patients have not participated in any physical activity program at least 6 months before the start of the study * Patients have chronic back pain \> 3months * Patients has non specific low back pain * Body mass index (BMI) from 25 to 34.9 kg/m2. * Patients are clinically and medically stable Exclusion Criteria: * Instability of patient's medical condition * Patients with chest infection * Inability to comprehend and follow instructions as in dementia or speech problems such as dysphasia, * uncontrolled diabetes mellitus, * Persistent systolic Blood Pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg * Chronic lung disease which result in significant oxygen desaturation on exercise or pulmonary congestion * Patients with lupus nephritis. * Patients with Spondylodiscitis , Compression fracture, Spinal stenosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hagar Atif Azab

    Cairo, Egypt